HERA Biotech is developing and commercializing a non-surgical diagnostic test for definitive diagnosis and staging of endometriosis.

HERA Biotech

Our Vision: To be the world leader in understanding & addressing diagnostic & therapeutic deficiencies in women's health. 
Our Mission: Driven to advance the standard of care in women's health 
Our First Order of Business: Validate and commercialize the first non-surgical method of diagnosing, and staging, endometriosis.

Althea Ventures

Kendra Scott Women's Entrepreneurial Leadership Institute

Stella Angels

Coyote Ventures

Hera Biotech

Hey, hey, hey!!! So proud that our company was selected from >1000 applicants as one of the 10 to participate in this, Class 10! Here we goooo!

So proud to see our CEO Somer Baburek, MBA, and our team at Hera being recognized for our work in #womenshealth!

At Hera, we are incredibly passionate about improving definitive diagnostics for endometriosis, taking it from surgical to simple, but always recognizing the importance of a tissue-based connection with a tissue-based disease. We also see the importance of elucidating the whole burden of endometriosis. It's easy to minimize the impact of something that is not directly affecting you or a loved one. We believe that endometriosis harms the whole of society, not just those that it immediately impacts, and we have dedicated precious resources to the research needed to prove this. 

We are so very pleased to present our 4th white paper in this series. We cannot thank Mark Gannott, A/Prof Mike Armour, Ryan Castle, Diana Nancy Contreras, MD MPH, Ally Schott, and Emma Ricci-De Lucca, the team that worked to get this paper done. This one was a heavy lift and they delivered something so data-driven, yet so easy to digest. Thank you to each of you, we are so appreciative of your dedication.

Please view the visual executive summary below and read the new Hera white paper here: https://lnkd.in/gwt8RzuC

#endometriosis #womenshealth #biotech #surgicaltosimple #socialdeterminantsofhealth

Experience, expertise, and innovation: Hera's team brings a wealth of knowledge in medical diagnostics development, approval, and more. MetriDx™, the groundbreaking diagnostic test for endometriosis, will expand access for OB/GYNs and fertility clinics. At Hera Biotech, our commitment lies in enhancing our understanding of endometriosis and creating an accessible diagnostic test for women grappling with this condition.

#FromSurgicalToSimple

Talking about endometriosis can be as tricky as explaining a color you've never seen. It's intimate, it's personal, and it's often met with misunderstanding. We know it can be difficult, but it doesn't have to be! Here are a few ways you can openly explain endometriosis to someone.
#FromSurgicalToSimple

Did you know there are incredible support groups like Endometriosis Association, EndoFound, SpeakEndo, and many more? Connect with others who understand your journey, share experiences, and access invaluable resources. You're not alone. 💛
#EndometriosisSupport #FromSurgicalToSimple

Metric
Company Name	HERA Biotech
Symbol
MSH ID	COM:HERABIOTECH
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage	Seed
Employee Count	5
Website	herabiotech.com
LinkedIn	hera-biotech
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.52K
Web Traffic Growth	-0.19
Valuation
Raised Capital	100K

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:HERABIOTECH

HERA Biotech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue